Correction to: Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson's Disease.

Requejo, C; Ruiz-Ortega, J A; Bengoetxea, H; Bulnes, S; Ugedo, L; Lafuente, J V

Requejo, C; Ruiz-Ortega, J A; Bengoetxea, H; Bulnes, S; Ugedo, L; Lafuente, J V.

Afiliación

Requejo C; LaNCE, Department of Neuroscience, University of the Basque, Country (UPV/EHU), Vizcaya, Leioa, Spain. catalina.requejo@ehu.eus.
Ruiz-Ortega JA; Department of Pharmacology, University of the Basque Country, (UPV/EHU), Vizcaya, Leioa, Spain.
Bengoetxea H; LaNCE, Department of Neuroscience, University of the Basque, Country (UPV/EHU), Vizcaya, Leioa, Spain.
Bulnes S; LaNCE, Department of Neuroscience, University of the Basque, Country (UPV/EHU), Vizcaya, Leioa, Spain.
Ugedo L; Department of Pharmacology, University of the Basque Country, (UPV/EHU), Vizcaya, Leioa, Spain.
Lafuente JV; LaNCE, Department of Neuroscience, University of the Basque, Country (UPV/EHU), Vizcaya, Leioa, Spain.

Mol Neurobiol ; 55(5): 4511, 2018 May.

Article en En | MEDLINE | ID: mdl-29504058

ABSTRACT

ABSTRACT

The authors found a terrible mistake in the manuscript. The legends from the Fig. 5 and 6 are interchanged. The Fig. 5 should be appeared with the legend from the Fig. 6 and Fig. 6 should be appeared with the legend from the Fig. 5.

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Mol Neurobiol Asunto de la revista: BIOLOGIA MOLECULAR / NEUROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: España

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google